Land: USA
Språk: engelska
Källa: NLM (National Library of Medicine)
FLUOCINOLONE ACETONIDE (UNII: 0CD5FD6S2M) (FLUOCINOLONE ACETONIDE - UNII:0CD5FD6S2M)
VersaPharm Inc. - an Akorn Company
FLUOCINOLONE ACETONIDE
FLUOCINOLONE ACETONIDE 0.11 mg in 1 mL
AURICULAR (OTIC)
PRESCRIPTION DRUG
Fluocinolone Acetonide Oil, 0.01% Ear Drops is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. This product contains refined peanut oil NF (see PRECAUTIONS ).
Fluocinolone Acetonide Oil, 0.01% Ear Drops is supplied in 1 fluid ounce bottles containing 20 mL, net weight (Dropper Included) (NDC 61748-250-20). Keep tightly closed. Store upright at 20° to 25°C (68 to 77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. To report SUSPECTED ADVERSE REACTIONS, contact VersaPharm Inc. at 1-877-254-4381 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. CAUTION: Rx only Manufactured by: Ei LLC Kannapolis, NC 28083 Marketed by: VersaPharm Inc. – An Akorn Company Lake Forest, IL 60045 FLUE00N Revised: 10-2016
Abbreviated New Drug Application
FLUOCINOLONE ACETONIDE- FLUOCINOLONE ACETONIDE OIL VERSAPHARM INC. - AN AKORN COMPANY ---------- FLUOCINOLONE ACETONIDE OIL, 0.01% EAR DROPS Rx only For Otic Use Only- Not for Ophthalmic Use DESCRIPTION Fluocinolone Acetonide Oil, 0.01% Ear Drops contain fluocinolone acetonide {(6α, 11β, 16α)-6,9- difluoro-11,21-dihydroxy- 16,17[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione, cyclic 16, 17 acetal with acetone}, a synthetic corticosteroid. Chemically, fluocinolone acetonide is C H F O . It has the following structural formula: Fluocinolone acetonide in Fluocinolone Acetonide Oil, 0.01% Ear Drops has a molecular weight of 452.50. It is a white crystalline powder that is odorless, stable in light, and melts at 270°C with decomposition; soluble in alcohol, acetone and methanol; slightly soluble in chloroform; insoluble in water. Each gram of Fluocinolone Acetonide Oil, 0.01% Ear Drops contains approximately 0.11 mg of fluocinolone acetonide in a blend of oils, which contains isopropyl alcohol, isopropyl myristate, light mineral oil, oleth-2, refined peanut oil NF and fragrances. CLINICAL PHARMACOLOGY Like other topical corticosteroids, fluocinolone acetonide has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A . PHARMACOKINETICS The extent of percutaneous absorption of topical corticosteroids is determined by many factors 24 30 2 6 2 2 including the vehicle and the integrity of the epidermal barrier. Occlusion of topical corticosteroids can enhance penetration. Topical corticoster Läs hela dokumentet